<qa>  What is the rate of complete response?1. Primary Research Question What are the rates of complete response CR, partial response PR, progression free survival PFS and overall survival OS in adult patients newly diagnosed with Peripheral T-Cell Lymphoma PTCL who are treated with alemtuzumab given in combination with CHOP cyclophosphamide, doxorubicin, vincristine and prednisolone and ESHAP etoposide, methylprednisolone, cisplatin, cytosine arabinoside administered as an up-front treatment? 